Published in J Membr Biol on May 01, 2004
Membrane fusion: grappling with SNARE and SM proteins. Science (2009) 8.98
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
Mechanics of membrane fusion. Nat Struct Mol Biol (2008) 4.79
Synaptic vesicle fusion. Nat Struct Mol Biol (2008) 4.22
Single reconstituted neuronal SNARE complexes zipper in three distinct stages. Science (2012) 2.98
Multiple intermediates in SNARE-induced membrane fusion. Proc Natl Acad Sci U S A (2006) 2.65
Line tension and interaction energies of membrane rafts calculated from lipid splay and tilt. Biophys J (2004) 2.35
Membranes of the world unite! J Cell Biol (2006) 2.06
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology (2008) 1.89
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 1.86
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation. Nature (2015) 1.85
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature (2015) 1.83
SNAREs can promote complete fusion and hemifusion as alternative outcomes. J Cell Biol (2005) 1.78
SNARE-catalyzed fusion events are regulated by Syntaxin1A-lipid interactions. Mol Biol Cell (2007) 1.62
The fusion pores of Ca2+ -triggered exocytosis. Nat Struct Mol Biol (2008) 1.57
A structural role for the synaptobrevin 2 transmembrane domain in dense-core vesicle fusion pores. J Neurosci (2015) 1.49
Ensemble molecular dynamics yields submillisecond kinetics and intermediates of membrane fusion. Proc Natl Acad Sci U S A (2006) 1.48
Conical electron tomography of a chemical synapse: vesicles docked to the active zone are hemi-fused. Biophys J (2006) 1.44
Synaptotagmin-1 utilizes membrane bending and SNARE binding to drive fusion pore expansion. Mol Biol Cell (2008) 1.42
IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog (2014) 1.42
Atomic-resolution simulations predict a transition state for vesicle fusion defined by contact of a few lipid tails. PLoS Comput Biol (2010) 1.42
Molecular mechanisms for synchronous, asynchronous, and spontaneous neurotransmitter release. Annu Rev Physiol (2013) 1.41
Characterization of a structural intermediate of flavivirus membrane fusion. PLoS Pathog (2007) 1.37
Viral and developmental cell fusion mechanisms: conservation and divergence. Dev Cell (2008) 1.32
Two synaptobrevin molecules are sufficient for vesicle fusion in central nervous system synapses. Proc Natl Acad Sci U S A (2011) 1.27
The SM protein Vps33 and the t-SNARE H(abc) domain promote fusion pore opening. Nat Struct Mol Biol (2010) 1.26
Transition from hemifusion to pore opening is rate limiting for vacuole membrane fusion. J Cell Biol (2005) 1.19
Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J Virol (2012) 1.17
Docking and fast fusion of synaptobrevin vesicles depends on the lipid compositions of the vesicle and the acceptor SNARE complex-containing target membrane. Biophys J (2010) 1.17
Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res (2008) 1.09
HIV-1 fusion peptide decreases bending energy and promotes curved fusion intermediates. Biophys J (2007) 1.08
Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys J (2007) 1.08
Single Molecule Measurements of Interaction Free Energies Between the Proteins Within Binary and Ternary SNARE Complexes. J Nanoneurosci (2009) 1.06
Liposome reconstitution of a minimal protein-mediated membrane fusion machine. EMBO J (2005) 1.02
Intracellular curvature-generating proteins in cell-to-cell fusion. Biochem J (2011) 1.02
SCAMP2 interacts with Arf6 and phospholipase D1 and links their function to exocytotic fusion pore formation in PC12 cells. Mol Biol Cell (2005) 1.02
A virus-encoded cell-cell fusion machine dependent on surrogate adhesins. PLoS Pathog (2008) 1.01
Minimum membrane bending energies of fusion pores. J Membr Biol (2009) 1.00
HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion. Biochemistry (2012) 0.99
The SNARE Machinery in Mast Cell Secretion. Front Immunol (2012) 0.98
Effect of surfaces on amyloid fibril formation. PLoS One (2011) 0.97
Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol (2008) 0.96
A hemi-fission intermediate links two mechanistically distinct stages of membrane fission. Nature (2015) 0.95
The polybasic juxtamembrane region of Sso1p is required for SNARE function in vivo. Eukaryot Cell (2005) 0.93
Reovirus FAST protein transmembrane domains function in a modular, primary sequence-independent manner to mediate cell-cell membrane fusion. J Virol (2009) 0.93
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry. PLoS Pathog (2015) 0.92
Muscarinic receptor stimulation activates a Ca(2+)-dependent Cl(-) conductance in rat distal colon. J Membr Biol (2005) 0.92
HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine (2008) 0.91
The Surprising Role of Amyloid Fibrils in HIV Infection. Biology (Basel) (2012) 0.91
Role of spike protein endodomains in regulating coronavirus entry. J Biol Chem (2009) 0.89
Membrane bridging and hemifusion by denaturated Munc18. PLoS One (2011) 0.89
Characterization of physical properties of supported phospholipid membranes using imaging ellipsometry at optical wavelengths. Biophys J (2006) 0.89
Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers. J Biol Chem (2013) 0.88
Enhanced fusion pore expansion mediated by the trans-acting Endodomain of the reovirus FAST proteins. PLoS Pathog (2009) 0.88
Membrane tension and membrane fusion. Curr Opin Struct Biol (2015) 0.88
Field theoretic study of bilayer membrane fusion III: membranes with leaves of different composition. Biophys J (2007) 0.88
The three lives of viral fusion peptides. Chem Phys Lipids (2014) 0.87
Role of PI(4,5)P(2) in vesicle exocytosis and membrane fusion. Subcell Biochem (2012) 0.87
The Atlastin C-terminal tail is an amphipathic helix that perturbs the bilayer structure during endoplasmic reticulum homotypic fusion. J Biol Chem (2015) 0.87
Receptor-induced thiolate couples Env activation to retrovirus fusion and infection. PLoS Pathog (2007) 0.86
Recruitment of HIV-1 envelope occurs subsequent to lipid mixing: a fluorescence microscopic evidence. Retrovirology (2009) 0.86
Distinct requirements for HIV-cell fusion and HIV-mediated cell-cell fusion. J Biol Chem (2015) 0.86
The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion. Virology (2010) 0.86
Pulling force generated by interacting SNAREs facilitates membrane hemifusion. Integr Biol (Camb) (2009) 0.84
The six-helix bundle of human immunodeficiency virus Env controls pore formation and enlargement and is initiated at residues proximal to the hairpin turn. J Virol (2009) 0.84
Stochastic fusion simulations and experiments suggest passive and active roles of hemagglutinin during membrane fusion. Biophys J (2014) 0.83
Magnesium-induced lipid bilayer microdomain reorganizations: implications for membrane fusion. J Phys Chem B (2009) 0.83
Computer-Aided Approaches for Targeting HIVgp41. Biology (Basel) (2012) 0.82
Coiled-coil formation on lipid bilayers--implications for docking and fusion efficiency. Biophys J (2012) 0.82
A Programmable DNA Origami Platform to Organize SNAREs for Membrane Fusion. J Am Chem Soc (2016) 0.81
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins. J Biol Chem (2017) 0.81
Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration. Mol Biol Cell (2014) 0.81
Simulations of skin barrier function: free energies of hydrophobic and hydrophilic transmembrane pores in ceramide bilayers. Biophys J (2008) 0.80
SNAREs: could they be the answer to an energy landscape riddle in exocytosis? ScientificWorldJournal (2010) 0.80
Placing and shaping liposomes with reconfigurable DNA nanocages. Nat Chem (2017) 0.80
Molecular dynamics simulation analysis of membrane defects and pore propensity of hemifusion diaphragms. Biophys J (2013) 0.80
The transmembrane domain peptide of vesicular stomatitis virus promotes both intermediate and pore formation during PEG-mediated vesicle fusion. Biophys J (2014) 0.80
Negative potentials across biological membranes promote fusion by class II and class III viral proteins. Mol Biol Cell (2010) 0.80
Fusion of Enveloped Viruses in Endosomes. Traffic (2016) 0.80
Adhesion energy can regulate vesicle fusion and stabilize partially fused states. J R Soc Interface (2012) 0.79
Structural insights into the membrane fusion mechanism mediated by influenza virus hemagglutinin. Biochemistry (2014) 0.79
An electrostatically preferred lateral orientation of SNARE complex suggests novel mechanisms for driving membrane fusion. PLoS One (2010) 0.79
Fusion pores and their control of neurotransmitter and hormone release. J Gen Physiol (2017) 0.78
Curvature-driven pore growth in charged membranes during charge-pulse and voltage-clamp experiments. Biophys J (2009) 0.77
Single-molecule measurements of dissociation rates and energy landscapes of binary trans snare complexes in parallel versus antiparallel orientation. Biophys J (2011) 0.77
Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. PLoS Pathog (2016) 0.77
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77
Investigating Hydrophilic Pores in Model Lipid Bilayers Using Molecular Simulations: Correlating Bilayer Properties with Pore-Formation Thermodynamics. Langmuir (2015) 0.77
A pressure-reversible cellular mechanism of general anesthetics capable of altering a possible mechanism for consciousness. Springerplus (2015) 0.76
Investigation of SNARE-Mediated Membrane Fusion Mechanism Using Atomic Force Microscopy. Jpn J Appl Phys (2008) (2009) 0.76
SNARE-mediated membrane fusion trajectories derived from force-clamp experiments. Proc Natl Acad Sci U S A (2016) 0.76
How Viruses Invade Cells. Biophys J (2016) 0.76
Dilation of fusion pores by crowding of SNARE proteins. Elife (2017) 0.75
The role of lateral tension in calcium-induced DPPS vesicle rupture. Langmuir (2012) 0.75
A framework for the first-person internal sensation of visual perception in mammals and a comparable circuitry for olfactory perception in Drosophila. Springerplus (2015) 0.75
The crossover conformational shift of the GTPase atlastin provides the energy driving ER fusion. J Cell Biol (2017) 0.75
Cholesterol Alters the Dynamics of Release in Protein Independent Cell Models for Exocytosis. Sci Rep (2016) 0.75
Reovirus FAST Proteins Drive Pore Formation and Syncytiogenesis Using a Novel Helix-Loop-Helix Fusion-Inducing Lipid Packing Sensor. PLoS Pathog (2015) 0.75
Entropic forces drive self-organization and membrane fusion by SNARE proteins. Proc Natl Acad Sci U S A (2017) 0.75
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A (1994) 8.48
Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys J (2000) 8.35
A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell (1993) 8.26
Structure of the dengue virus envelope protein after membrane fusion. Nature (2004) 7.97
Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci U S A (1974) 7.95
Membrane fusion. Cell (2003) 7.68
A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol (1995) 7.30
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell (1994) 5.65
Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem (2003) 4.77
Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol (2001) 4.66
Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26
The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol (2003) 4.21
Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol (1993) 4.19
The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol (1998) 4.07
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature (2004) 4.02
Protein-mediated membrane fusion. Annu Rev Biophys Biophys Chem (1989) 3.99
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
Energetics of intermediates in membrane fusion: comparison of stalk and inverted micellar intermediate mechanisms. Biophys J (1993) 3.82
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J Virol (1992) 3.54
Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol (1987) 3.52
Stalk model of membrane fusion: solution of energy crisis. Biophys J (2002) 3.51
Lipids in biological membrane fusion. J Membr Biol (1995) 3.40
GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J Cell Biol (1995) 3.34
Observation of a membrane fusion intermediate structure. Science (2002) 3.30
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol (1995) 3.11
Hydration forces. Annu Rev Phys Chem (1993) 3.02
A quantitative model for membrane fusion based on low-energy intermediates. Proc Natl Acad Sci U S A (2001) 3.01
Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J Cell Biol (1994) 2.87
Membrane fusion: stalk model revisited. Biophys J (2002) 2.83
Intermolecular forces in biology. Q Rev Biophys (2001) 2.77
The hydrophobic interaction is long range, decaying exponentially with distance. Nature (1982) 2.61
Fusion of cells by flipped SNAREs. Science (2003) 2.60
Measured effects of diacylglycerol on structural and elastic properties of phospholipid membranes. Biophys J (1996) 2.50
Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol (1997) 2.47
The electrical breakdown of cell and lipid membranes: the similarity of phenomenologies. Biochim Biophys Acta (1987) 2.41
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion. Curr Opin Cell Biol (1995) 2.31
The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys J (1999) 2.30
Flickering fusion pores comparable with initial exocytotic pores occur in protein-free phospholipid bilayers. Proc Natl Acad Sci U S A (1997) 2.25
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion. J Cell Biol (1993) 2.24
On the theory of membrane fusion. The stalk mechanism. Gen Physiol Biophys (1984) 2.22
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol Biol Cell (2003) 2.18
The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition. J Cell Biol (2000) 2.13
The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes. Biophys J (2001) 2.12
Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol Biol Cell (1999) 2.10
The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion. J Biol Chem (1991) 2.07
Membrane fusion: overcoming of the hydration barrier and local restructuring. J Theor Biol (1987) 2.05
Evolution of lipidic structures during model membrane fusion and the relation of this process to cell membrane fusion. Biochemistry (1997) 2.01
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
Lipid intermediates in membrane fusion: formation, structure, and decay of hemifusion diaphragm. Biophys J (2002) 2.00
The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1998) 1.99
Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide". J Biol Chem (1989) 1.96
What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). Mol Membr Biol (1998) 1.94
Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J Virol (1999) 1.89
GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J Cell Biol (1993) 1.78
Visualization of the target-membrane-inserted fusion protein of Semliki Forest virus by combined electron microscopy and crystallography. Cell (2003) 1.67
A new mechanism of model membrane fusion determined from Monte Carlo simulation. Biophys J (2003) 1.65
The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell (2000) 1.59
Role of hydrophobic forces in bilayer adhesion and fusion. Biochemistry (1992) 1.58
Multiple local contact sites are induced by GPI-linked influenza hemagglutinin during hemifusion and flickering pore formation. Traffic (2000) 1.50
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J Virol (2003) 1.43
A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol Biol Cell (2000) 1.43
Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J Virol (1997) 1.43
Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J Cell Biol (2001) 1.42
Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. J Biol Chem (1993) 1.40
Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J Virol (2001) 1.38
Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc Natl Acad Sci U S A (2001) 1.37
Leash in the groove mechanism of membrane fusion. Nat Struct Biol (2003) 1.36
Membrane mechanics can account for fusion pore dilation in stages. Biophys J (1995) 1.33
The effects of acyl chain length and saturation of diacylglycerols and phosphatidylcholines on membrane monolayer curvature. Biophys J (2002) 1.33
The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores. Virology (1997) 1.31
A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol (2004) 1.30
Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology (1996) 1.29
Dynamics of fusion pores connecting membranes of different tensions. Biophys J (2000) 1.25
The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J Mol Biol (1999) 1.25
Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J (1995) 1.24
Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics. EMBO J (2001) 1.23
The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion. Mol Biol Cell (1999) 1.19
Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion. J Virol (1999) 1.17
Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin. Biophys J (1997) 1.16
Structure and energy of fusion stalks: the role of membrane edges. Biophys J (2002) 1.14
Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes. Biochemistry (1997) 1.14
New phases of phospholipids and implications to the membrane fusion problem. Biochemistry (2003) 1.12
Thermodynamics of fusion peptide-membrane interactions. Biochemistry (2003) 1.10
Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J Virol (2000) 1.10
Asymmetric membranes resulting from the fusion of two black lipid bilayers. Biochim Biophys Acta (1974) 1.06
Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology (2003) 1.06
The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion. Biochemistry (2001) 1.05
Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion. J Virol (2003) 1.03
Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein. J Mol Biol (2001) 1.03
Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. Biochim Biophys Acta (1987) 2.91
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores. Mol Biol Cell (2000) 1.59
Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J Virol (2003) 1.43
Effects of spontaneous bilayer curvature on influenza virus-mediated fusion pores. J Gen Physiol (1998) 1.36
Tension of membranes expressing the hemagglutinin of influenza virus inhibits fusion. Biophys J (1999) 1.24
Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology (2003) 1.06
A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. Biophys J (2004) 1.03
Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation. Biophys J (2001) 0.99
Methodologies in the study of cell-cell fusion. Methods (1998) 0.98
Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function. AIDS Res Hum Retroviruses (1992) 0.96
Implications of a fusion peptide structure. Nat Struct Biol (2001) 0.91
Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge. Biophys J (1999) 0.90
Interaction of human immunodeficiency virus (HIV-1) fusion peptides with artificial lipid membranes. Biochem Biophys Res Commun (1990) 0.81
Interaction of ganglioside-containing planar bilayers with serotonin and inorganic cations. Biochim Biophys Acta (1989) 0.75